# Cell-culture viral vaccines: Materials

Source page: https://www.materialinsights.org/technologies/cell_culture_vaccines/tech-materials/

#### Materials it needs

The commodities and chemicals it needs per unit, its share of each one's demand and how critical each is
 Uses

- [Exc Pharmaceutical excipients](https://www.materialinsights.org/chemicals/excipients/) criticality low Finished vaccines are formulated with common stabilisers and salts so the vial keeps its potency.
 Needs

- [Qz Silica sand](https://www.materialinsights.org/commodities/industrial_sand/) criticality low Vaccines are filled into glass vials, made mostly from silica sand.

as of 2026-11-10. Dual-use node: only broad, harmless inputs are named, with no amounts, units, recipes or conditions. Inputs that would describe how a vaccine virus is grown are left out under the dual-use rule. Criticality is a judgement; both are common materials.

#### Critical materials

The materials whose supply could hold it back

- No raw material is likely to hold these vaccines back: the inputs are common chemicals and glass.
- The real constraints are policy ones: licensed production capacity, batch release by regulators, and the cold chain that keeps vaccines potent on the way to clinics.
- Supply is concentrated in a few qualified plants, so a national programme's security of supply is a procurement and policy question rather than a materials one.

as of 2026-11-10

## Other sections

- [Summary](https://www.materialinsights.org/technologies/cell_culture_vaccines/index.md)
- [Overview](https://www.materialinsights.org/technologies/cell_culture_vaccines/tech-overview/index.md)
- [Science](https://www.materialinsights.org/technologies/cell_culture_vaccines/tech-science/index.md)
- [Evolution](https://www.materialinsights.org/technologies/cell_culture_vaccines/tech-evolution/index.md)
- [Energy footprint](https://www.materialinsights.org/technologies/cell_culture_vaccines/tech-energy-footprint/index.md)
- [Industries](https://www.materialinsights.org/technologies/cell_culture_vaccines/tech-industries/index.md)
